| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $883.4M | +43.8% |
| R&D Expense | $51.7M | +15.9% |
| SG&A Expense | $317.7M | +27.3% |
| Operating Income | $111.1M | — |
| Interest Expense | $32.6M | -3.2% |
| Pre-tax Income | $95.8M | +531.3% |
| Income Tax | $17.5M | +573.0% |
| Net Income | $78.3M | +522.9% |
| EPS (Basic) | $3.50 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $285.6M | +97.1% |
| Accounts Receivable | $281.1M | +26.8% |
| Inventory | $143.1M | +4.6% |
| Current Assets | $753.1M | +42.7% |
| Total Assets | $1.44B | +12.2% |
| Current Liabilities | $278.1M | +43.6% |
| Long-term Debt | $291.8M | -5.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $185.2M | +189.3% |
| Capital Expenditures | $13.8M | -14.8% |
| Investing Cash Flow | -$34.3M | +91.5% |
| Financing Cash Flow | -$9.9M | -103.8% |
| Free Cash Flow | $171.4M | +258.7% |
| +436.5% |
| EPS (Diluted) | $3.32 | +419.2% |
| Total Liabilities |
| $899.7M |
| +5.2% |
| Stockholders' Equity | $540.7M | +33.9% |